1 completed, 1 terminated, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Substance Use Disorder: new trials by email Literature Review of Substance Use Disorder trials Research Report on Substance Use Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance Methylphenidate, Placebo - Attention Deficit Hyperactivity Disorder, Substance Use Disorder | Phase 4 | Completed | Region Västmanland | 39 | 2016-09-01 | 2023-05-06 |
| Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed Veterans Quetiapine, Trazodone - Insomnia, Mental Health Disorder | Phase 4 | Terminated | VA Connecticut Healthcare System | 1 | 2012-07-01 | 2018-10-16 |
| Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD Atomoxetine, Placebo - Attention Deficit Hyperactivity Disorder, Substance Use Disorder | Phase 4 | Withdrawn | Massachusetts General Hospital | 2013-03-05 |
Substance-Related Disorders (3) · Attention Deficit Disorder with Hyperactivity (2) · Mental Disorders (1) · Sleep Initiation and Maintenance Disorders (1)
Chemically-Induced Disorders (3) · Attention Deficit and Disruptive Behavior Disorders (2) · Mental Disorders (2) · Neurodevelopmental Disorders (2) · Dyssomnias (1) · Nervous System Diseases (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
Atomoxetine Hydrochloride (1) · Methylphenidate (1) · Quetiapine Fumarate (1) · Trazodone (1)
Massachusetts General Hospital (1) · Region Västmanland (1) · VA Connecticut Healthcare System (1)
United States (2) · Sweden (1)
Albert J Arias, MD, MS (1) · Elizabeth Ralevski, Ph.D. (1) · Lennart Jansson, PhD (1) · Timothy Wilens, MD (1)
2014 (1), K24DA016264 (1)